Gardner, PJLoynachan, CTsekoa, Tsepo LKeir, LYabannavar, VSparrow, E2026-03-102026-03-102025-042731-6092https://doi.org/10.1038/s44222-025-00301-whttp://hdl.handle.net/10204/14734Biopharmaceutical manufacturing innovation is essential for making monoclonal antibodies affordable and accessible by overcoming critical cost and supply barriers. Importantly, innovation supporting regional production will be required to meet low- and middle-income country health needs and strengthen global resilience against future infectious disease outbreaks.AbstractenBiopharmaceutical manufacturing innovationBioengineeringMonoclonal antibodiesArticleN/A